Secukinumab
(Anti-human IL-17A mAb, human IgG1-Kappa; AIN-457)
Catalog No.: PC-Ab1019Not For Human Use, Lab Use Only.
Secukinumab (Cosentyx) is a human monoclonal antibody designed for the treatment of uveitis, rheumatoid arthritis, ankylosing spondylitis, and psoriasis. Secukinumab is an interleukin-17A (IL-17A) inhibitor By targeting IL-17A. Secukinumab has shown excellent efficacy in psoriasis by normalizing skin histology..
Secukinumab (Cosentyx) is a human monoclonal antibody designed for the treatment of uveitis, rheumatoid arthritis, ankylosing spondylitis, and psoriasis. Secukinumab is an interleukin-17A (IL-17A) inhibitor By targeting IL-17A. Secukinumab has shown excellent efficacy in psoriasis by normalizing skin histology.
Physicochemical Properties
M.Wt
Formula
Human IgG1-Kappa
Appearance
Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility
PBS, pH 7.0
Contains no stabilizers or preservatives
